Refine by
Locations
- USA
- Alabama
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- Delaware
- District Of Columbia
- Florida
- Georgia (USA)
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Louisiana
- Maine
- Maryland
- Massachusetts
- Michigan
- Minnesota
- Mississippi
- Missouri
- Montana
- Nebraska
- Nevada
- New Hampshire
- New Jersey
- New Mexico
- New York
- North Carolina
- North Dakota
- Ohio
- Oklahoma
- Oregon
- Pennsylvania
- Rhode Island
- South Carolina
- South Dakota
- Tennessee
- Texas
- Utah
- Vermont
- Virginia
- Washington
- West Virginia
- Wisconsin
- Wyoming
Heparin Therapy Equipment & Supplies In USA
5 equipment items found
Manufactured by:Helena Laboratories based in
With a low ISI assignment less than 1.50, this reagent offers reliable sensitivity to liver disease, depression of Vitamin K dependent factors, and coumarin-induced coagulation, even in the presence of high-dose heparin therapy. Open reagent is stable 14 days at ...
Manufactured by:Emosis Diagnostics SAS based inIllkirch-Graffenstaden, FRANCE
HIT Confirm test kit has been CE-marked in March 2018 for the purpose of helping to establish the diagnosis of Heparin-Induced Thrombocytopenia (HIT). The kit is available for research use only (RUO) in non-CE mark regulated countries. HIT is a rare, but life-threatening, disorder that is frequently suspected in hospital in-patients treated with heparin (an ...
Manufactured by:NIKKISO Belgium BV. based inTienen, BELGIUM
Designed for use on the Aquarius™ System, Aquaset™ disposables conveniently combine an Aquamax™ filter with an Aqualine™ ...
Manufactured by:NIKKISO Belgium BV. based inTienen, BELGIUM
Designed for use on the Aquarius™ System with Aquarius+ Software or 6.02.09, CitrasetRCA disposables conveniently combine an Aquamax™ filter with an Aqualine™ RCA ...
Manufactured by:BioMedica Diagnostics based inWindsor, NOVA SCOTIA (CANADA)
ACTICHROME Heparin (Anti-FIIa) is an in vitro diagnostic three-stage assay. It begins with plasmas containing heparin interacting with human antithrombin III to form a heparin-ATIII complex. In the second stage, thrombin is added, which the complex inhibits. The third stage involves the residual thrombin activity hydrolyzing SPECTROZYME TH, a chromogenic substrate. This design ensures that the ...